Jessica B. Back

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Guidelines for establishing a cytometry laboratory”.

Guidelines for establishing a cytometry laboratory

Cytometry Part A(2023)10.1002/cyto.a.24807

N/A

0.269DataRank · unranked

5 citations

Caroline E. Roe, Vera A. Tang, Jessica B. Back, Claúdia Bispo, Alexis Conway +21 more

Shared Resource Laboratory Operations: Changes Made During Initial Global COVID‐19 Lockdown of 2020

Cytometry Part A(2020)10.1002/cyto.a.24261

N/A

0DataRank · unranked

7 citations

Cora H. Chadick, Juan J. García‐Vallejo, Eva Orlowski‐Oliver, Radhika Patel, Caroline E. Roe +3 more

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment

Scientific Reports(2022)10.1038/s41598-022-14788-5

N/A

0DataRank · unranked

15 citations

Lisa Rubinsak, Agnes Malysa, Sijana H. Dzinic, Manasa Ravindra, Mathew Schneider +11 more

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

NAR Cancer(2023)10.1093/narcan/zcac045

N/A

0DataRank · unranked

11 citations

Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher K. Yunker, Vilvanathan Vinothkumar +13 more

Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0550

N/A

0DataRank · unranked

15 citations

Carrie O’Connor, Aamod S. Dekhne, Xun Bao, Md. Junayed Nayeen, Mathew Schneider +11 more

Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia

ASPET Discovery(2025)10.1016/j.aspetd.2025.100014

N/A

0DataRank · unranked

0 citations

Jianlei Zhao, Jenna Thibodeau, Holly Edwards, Jing Li, Xun Bao +12 more